Skip to main content
logo
Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
5.70
-0.62 (-9.81%)
At close: Jun 12, 2026, 4:00 PM EDT
5.90
+0.20 (3.51%)
After-hours: Jun 12, 2026, 7:29 PM EDT

Seres Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-46.95.70.14-113.72-250.16-65.58
Depreciation & Amortization
3.844.135.476.246.635.95
Stock-Based Compensation
9.7910.8420.9734.125.4820.22
Other Adjustments
8.448.23-109.68157.624.57
Change in Receivables
2.881.55-2.07---
Changes in Inventories
---33.8-29.65-9.39
Changes in Accounts Payable
0.23-2.4-2.94-11.582.29.36
Changes in Accrued Expenses
-13.72-20.98-25.915.843.3443.03
Changes in Unearned Revenue
---4.126.41-7.13-4.36
Changes in Other Operating Activities
-6.35-5.953.32-40-16.8-15.89
Operating Cash Flow
-42.151.12-148.61-117.35-228.826.69
Capital Expenditures
-0.22-0.25-0.38-7.98-9.82-9.57
Sale of Property, Plant & Equipment
-0.21----
Purchases of Investments
----4.43-48.22-95.97
Proceeds from Sale of Investments
--1.422.98140.47169.63
Proceeds from Business Divestments
--141.27---
Investing Cash Flow
-0.01-0.04142.2910.5882.4364.09
Long-Term Debt Issued
---103.3827.61-
Long-Term Debt Repaid
---127.91-52.86-1.91-0.95
Net Long-Term Debt Issued (Repaid)
---127.9150.5225.7-0.95
Issuance of Common Stock
13.1313.937.5321.19103.92.13
Net Common Stock Issued (Repurchased)
13.1313.937.5321.19103.92.13
Financing Cash Flow
13.1513.9-90.3771.71129.61.18
Effect of Exchange Rate Changes on Cash and Cash Equivalents
---00-0-0
Net Cash Flow
-29.0214.97-96.69-35.07-16.7971.95
Free Cash Flow
-42.370.87-148.99-125.33-238.64-2.88
FCF Margin
-3694.07%109.63%----1.99%
Free Cash Flow Per Share
-4.660.10-19.18-19.58-44.16-0.63
Levered Free Cash Flow
-36.14-19.75-186.12-123.92-109.61-28.62
Unlevered Free Cash Flow
-103.87-119.42-179.67-255.81-216.68-26.58
SEC Filings: 10-K · 10-Q